Pfizer accused of mismarketing Neurontin; Type 1 diabetes vaccine may help with management;

> Once again, Pfizer faces allegations that it has been marketing its drug Neurontin deceptively, putting a positive spin on what was actually negative research. FiercePharma

> This may offer some new help with one of the world's most common and expensive chronic illnesses. A new vaccine developed by a Swedish team of scientists may help children and adolescents diagnosed with Type 1 diabetes better manage the disease, researchers say. FierceVaccines

> Blue Cross is having a knock-down, drag-out dispute with the Care New England Hospital group, and no one's sure how things will shake out in the market if they don't work it out quickly. Article

> Is running a hospital anything like being a band leader? Retired hospital CEO Nick Jacobs explains why he believes it is. HospitalImpact

And Finally... Even for free, I doubt this would be worth the hassle. But hey, there is the Benji factor. Article